ArticlePloS one2025
Achieving immunization milestones: Insights from Oman's national coverage survey.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The studies primary objective was to determine the actual immunization coverage by validating routine immunization data and conducting a community-level survey at the sub-national level for different age groups in Oman. A cross-sectional community survey to assess vaccination coverage in Oman was done using the WHO cluster sampling method on children under five eligible for various vaccines, including BCG, HBV, OPV, PCV, Penta, Hexa, MMR, Varicella, and Hepatitis A. The survey was conducted between 20th February 2023 and 19th March 2023. Face-to-face interviews using a pretested electronic questionnaire gathered the information. Descriptive statistics and chi-square tests for categorical data analysis were performed. Vaccination outcomes were classified as fully vaccinated, partially vaccinated, or unvaccinated, with 95% confidence intervals reported. The crude national vaccination coverage was nearly 100% in Oman. The fully vaccinated coverage ranged from 87% to 99%. Only one child (0.01%) was unvaccinated, and 1.3% of children were partially vaccinated. Children in Muscat and Dhofar had lower odds of being fully vaccinated compared to other governorates and Omani children were significantly more likely to be fully vaccinated compared to non-Omani children. There was a difference in the crude coverage and valid coverage indicating there is a delay in vaccination (>30 days from the scheduled date) as the age progresses. The national immunization coverage fully complied with the administrative coverage. The high vaccination coverage indicates universal acceptance of vaccination program in Oman. Delayed vaccination due to acute illness around the due date of vaccination was a significant observation that needs attention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.